December 4-5, 2012 • San Jose Convention Center • San Jose, CA
The combination drug-device industry is a dynamic growth sector that is valued at more than $8 billion. Established devices such as drug-eluting stents, metered-dose inhalers, and transdermal patches are being joined by a wide range of new applications across the entire device marketplace as biopharmaceutical manufacturers partner with medical OEMs in the development of exciting new drug-device combinations.
Returning for its fifth year, BIOMEDevice serves this dynamic growth sector at the San Jose McEnery Convention Center in the San Francisco Bay area, at the heart of one of the nation's largest concentrations of medical device manufacturing-home to more than 3,600 medical device and biopharma producers. The region is frequently cited as hosting the largest contingency of medical device start-ups in the country.
The BIOMEDevice Exposition features 350 leading OEM suppliers interested in reaching this valuable, untapped medical device manufacturing region. The BIOMEDevice audience includes thousands of medical design and manufacturing professionals, biopharma development and manufacturing professionals, and senior executives focused on new product innovation and development. BIOMEDevice fosters collaborative new product development and partnering between medical OEM and biopharma executives.
| FEATURES IN 2012 |
|
Quality Contract Manufacturing Biomaterials |
BIOMEDevice Conference |
